172 filings
Page 5 of 9
8-K
k7kzu9qyj dxw36sk
10 Feb 20
Other Events
7:06am
8-K
u253csue9
9 Dec 19
Entry into a Material Definitive Agreement
8:15am
8-K
aus325iinmq9 pzjk
4 Nov 19
Trevena Reports Third Quarter 2019 Results and Topline Data From Multi-Dose Healthy Volunteer QT Study
7:02am
8-K
vflpo0ndfwkk54k2k
6 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
ux0dpl hvnf
7 Aug 19
Trevena Reports Second Quarter 2019 Results
7:02am
8-K
ndebzv65o7 xu0bysvg
27 Jun 19
Trevena Appoints Barry Shin as Chief Financial Officer
7:05am
8-K
hyx4o chz
17 May 19
Submission of Matters to a Vote of Security Holders
9:16am
8-K
mc46h3yazxq9us4y5em0
10 May 19
Trevena Reports First Quarter 2019 Results
7:03am
8-K
0r4 eb1izj
17 Apr 19
Entry into a Material Definitive Agreement
5:04pm
8-K
rl8s1c1 lsykc
13 Mar 19
Trevena Reports Fourth Quarter and Full Year 2018 Results
7:03am
8-K
u123i
7 Mar 19
Other Events
4:02pm
8-K
cy59j3 jf0b
1 Mar 19
Departure of Directors or Certain Officers
4:01pm
8-K
mu5c5jhbsz
11 Feb 19
Other Events
4:01pm
8-K
u960jooqt g4we
1 Feb 19
Entry into a Material Definitive Agreement
9:30am
8-K
wowh0vev9 56nfmaek
30 Jan 19
Trevena Announces $10 Million Registered Direct Offering of Common Stock
7:13am
8-K
1bvia0vg28dwlz7 ol
28 Jan 19
Trevena Announces Receipt of Type A Meeting Minutes and Provides Regulatory Update for Oliceridine
7:05am
8-K
p4lk2
21 Dec 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
8-K
f8jvvt0mbpr123wr
8 Nov 18
Trevena Reports Third Quarter 2018 Financial Results and Announces Workforce Restructuring
7:06am
8-K
v4mqd2
2 Nov 18
Trevena Receives Complete Response Letter for Oliceridine from FDA
4:01pm
8-K
hg7ttl
17 Oct 18
Entry into a Material Definitive Agreement
4:26pm